Persyst Development

Solana Beach, California, United States  All United States companies → Founded 1987
Specialty-Focused AI
Critical Care Neurology
Neurology AI
Funding Raised (Grant) — undisclosed

Products

Persyst 14 EEG Review and Analysis Software
Persyst Development Corporation
Neurology AI
Persyst 14 EEG Review and Analysis Software offers AI-powered seizure and spike detection, continuous artifact reduction, and comprehensive trending for neurologists. It integrates seamlessly with major EEG systems and is used by top neurology hospitals.

See all 1 product →

About Persyst Development

Persyst Development Corporation is a leading healthcare AI company specializing in advanced electroencephalography (EEG) analysis products. Their flagship software, Persyst 15, provides a comprehensive suite of tools for Computer Assisted Review of EEG (C.A.R.E), which includes sophisticated seizure and spike detection, customizable EEG trends, and real-time artifact reduction. The software is widely adopted, with 97 out of 100 of the top hospitals for Neurology in the U.S. reportedly using Persyst for EEG monitoring and review.

For physicians, Persyst’s solutions are designed to enhance efficiency and improve patient outcomes across various clinical environments, including continuous EEG monitoring, long-term monitoring (LTM), and ambulatory EEG. The company leverages deep learning and artificial intelligence to develop clinically validated advances, such as the Persyst Seizure Detector, which has demonstrated high sensitivity and a low false positive rate for adult EEG data, and a new Neonatal Seizure Detector. Persyst also offers mobile solutions like Persyst Mobile, enabling secure and quick remote EEG review on web, iOS, or Android devices, and supports intracranial EEG (iEEG) analysis with tools for electrode localization and trending.

Focus Areas

Seizure Detection Spike Detection Quantitative EEG Analysis Artifact Reduction EEG Trending EEG Electrical Source Imaging (ESI) Intracranial EEG (iEEG) Analysis Continuous EEG Monitoring Long-Term Monitoring (LTM) Ambulatory EEG Neonatal Seizure Detection Neurocritical Care Monitoring

Business Intelligence

Key InvestorsNone known (traditional VC funding)
PartnershipsEpilog (for ESI), Nihon Kohden America, Neurovirtual, Natus Neurology (including Natus BrainWatch), Micromed, Compumedics Limited, Cadwell Laboratories, Inc., Moberg ICU Solutions
TechnologyAI, Deep Learning, Cloud-native (for ESI), Windows-based software, integrated with major EEG manufacturers' hardware and software, PACS integration
FDA ClearancesMultiple (at least 2 for Persyst 15 EEG Review and Analysis Software: K252160, K222002) cleared products (estimated)

What Physicians Need to Know

Seizure Detection
Persyst utilizes advanced neural network technology and deep learning to provide highly sensitive (up to 95% for adult EEG) and accurate seizure detection with a significantly lower false positive rate compared to previous generations. It includes a specialized Neonatal Seizure Detector capable of operating on reduced electrode arrays, and offers near real-time notifications to assist clinicians in monitoring.
Spike Detection
The software employs advanced neural networks across various montages to identify sharps and spikes, analyzing EEG background, artifact presence, waveform morphology, and voltage field spread. Recent updates have improved accuracy, particularly in pediatric and normal EEGs, and refined the distinction between generalized and focal spikes, freeing up clinician time for advanced analysis.
Quantitative EEG Analysis (qEEG) & EEG Trending
Persyst Trending offers a comprehensive and flexible solution for quantitative EEG analysis, extracting statistical features not immediately apparent in raw EEG. It provides customizable tools for calculating and displaying various trends, all based on Artifact Reduction to ensure the trends primarily represent cerebral activity. This enhances diagnostic capabilities and improves efficiency in reviewing long EEG recordings.
Artifact Reduction
Persyst provides robust artifact reduction capabilities, including push-button removal of EMG, eye movement, and electrode artifacts from standard 10-20 EEG recordings. This feature is crucial for improving the interpretability of EEG features, trends, and detection results, leading to more accurate analysis and fewer false positives.
EEG Electrical Source Imaging (ESI)
Persyst ESI is a neuroimaging modality that co-registers a patient's EEG data with their MRI to localize the source of scalp EEG signals within the brain. It offers sub-lobar accuracy using Current Density Reconstruction (sLORETA) and patient-specific head models, making it a practical and accessible tool for presurgical evaluation without requiring additional hardware or specialized expertise.
Intracranial EEG (iEEG) Analysis
Persyst offers tools for iEEG imaging and analysis, although specific performance for spike detection in intracranial recordings has not been assessed.
Continuous EEG Monitoring & Long-Term Monitoring (LTM)
The software is integrated with major EEG acquisition systems, providing time-synchronized, continuous trending of EEG and physiological data, along with online spike and seizure detection during acquisition. It supports multi-patient monitoring and offers solutions for remote access and review, ideal for EMU and ICU settings.
Ambulatory EEG
Persyst provides review capabilities for ambulatory EEG, including artifact reduction, spike detection, and seizure detection for supported formats.
Neonatal Seizure Detection
A dedicated Neonatal Seizure Detector in Persyst 15 allows clinicians to efficiently assess and quantify seizure burden in neonates, even with reduced electrode arrays (down to three electrodes).
Neurocritical Care Monitoring
Persyst offers solutions tailored for neurocritical care environments, providing comprehensive EEG monitoring and analysis to support critical patient management.
Physician Tip

For physicians, Persyst Development's software, particularly Persyst 15, stands out by significantly enhancing efficiency and accuracy in EEG interpretation. The advanced AI and deep learning algorithms for seizure and spike detection can reduce review time and minimize missed events, improving patient safety and outcomes. The comprehensive trending and artifact reduction tools provide clearer insights into cerebral activity, while EEG Electrical Source Imaging (ESI) offers practical localization of seizure sources. The seamless integration with major EEG systems and mobile accessibility (Persyst Mobile) allow for flexible and timely patient monitoring and review, whether at the bedside or remotely. This translates to more informed clinical decision-making and streamlined workflows in busy clinical practices.

Persyst is uniquely integrated with all major EEG manufacturers, including Micromed, Natus, Nihon Kohden, Cadwell, and Compumedics. This comprehensive integration ensures compatibility and ease of use, facilitating seamless adoption in diverse clinical settings. The software also supports mobile platforms (iOS, Android, Web) for remote monitoring and review.

Products by Persyst Development

1 product in the directory

Persyst 14 EEG Review and Analysis Software
Persyst Development Corporation
Neurology AI
Persyst 14 EEG Review and Analysis Software offers AI-powered seizure and spike detection, continuous artifact reduction, and comprehensive trending for neurologists. It integrates seamlessly with major EEG systems and is used by top neurology hospitals.

Reviews & Opinions

No web reviews on file yet for Persyst Development. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Persyst Development.

Loading videos...

Videos load interactively. If none appear, search YouTube for Persyst Development →

View all on YouTube

Press & Coverage

FDA
Persyst 15 EEG Review and Analysis Software Receives FDA 510(k) Clearance
Persyst Development LLC received 510(k) clearance from the FDA for its Persyst 15 EEG Review and Analysis Software, intended for review, monitoring, and analysis of EEG recordings to aid neurologists. The clearance, dated October 31, 2025, covers features like seizure detection, spike detection, and quantitative EEG analysis.
2025-10
PR Newswire
Natus announces FDA 510(k) clearance for electrographic status epilepticus diagnostic indication in BrainWatch point-of-care EEG solution
Natus Medical Incorporated announced FDA 510(k) clearance for the electrographic status epilepticus diagnosis capability of its BrainWatch point-of-care EEG solution, which integrates Persyst 15 analysis software. This allows for improved diagnosis and monitoring of electrographic status epilepticus.
2025-12
Journal of Integrative Neuroscience
Diagnostic Accuracy of the Persyst Automated Seizure Detector in the Neonatal Population
A study published in August 2024 found that the Persyst neonatal automated seizure detection algorithm (SDA) demonstrates high diagnostic accuracy in identifying neonatal seizures, comparable to adult SDAs and amplitude-integrated EEG. The study suggests further investigation is needed to confirm optimal seizure probability thresholds in a larger patient cohort.
2024-08
Persyst Development LLC
Persyst 15 Release
Persyst 15, released in November 2023, introduces significant enhancements including a new neonatal-specific seizure detector leveraging deep learning and AI, improved neuroimaging tools with an MRI viewer for ESI results, and enhanced spike review capabilities. It also features Persyst Prime for optimized support and access to advanced clinical tools.
2023-11
Persyst Development LLC
Persyst Mobile and Mobile Bridge Release
Persyst Mobile, a universal EEG monitoring and review application for iOS, Android, and Web, was released in November 2023. It offers secure, end-to-end encrypted access to EEG data, trends, and video, integrating with hospital security infrastructure.
2023-11
Journal of Neurology
Real-world evaluation of an automated EEG spike detection software in a tertiary centre compared to a clinical reference standard
A January 2026 study evaluated the Persyst P15 spike detection software, finding a high negative predictive value (96.3%) for ruling out interictal epileptiform discharges (IEDs) in routine EEGs, but a low positive predictive value (19.9%). This suggests Persyst is good for ruling out IEDs but may produce many false positives.
2026-01
Persyst Development LLC
Persyst 15Rev.C Release Notes
Persyst 15Rev.C, released in February 2026, includes major enhancements for visualizing and analyzing multi-modal iEEG data, PACS integration for direct DICOM image upload, and an improved spike detector with increased sensitivity and decreased false positives, especially in pediatric and normal EEG data.
2026-02
Journal of Neurology, Neurosurgery & Psychiatry
Evaluation of the accuracy of the Persyst system in automated detection of interictal epileptiform discharges
A study is underway to evaluate the Persyst system's accuracy in detecting interictal epileptiform discharges (IEDs) against a trained neurophysiologist's assessment in a large, heterogeneous patient cohort. This validation is crucial for clinical adoption and trust in the automated system.
unknown

Frequently Asked Questions

Persyst Development's software, particularly Persyst 15, provides comprehensive tools for continuous and long-term EEG monitoring, including real-time seizure and spike detection, quantitative EEG analysis, and artifact reduction. It offers customizable EEG trending, which is crucial for efficiently reviewing extensive recordings in both ICU and epilepsy monitoring unit (EMU) settings.
Persyst 15 includes advanced tools for Intracranial EEG (iEEG) analysis, featuring intracranial electrode localization with millimeter resolution and automated montage and trend creation to streamline review of complex datasets. For Electrical Source Imaging (ESI), Persyst integrates with Epilog's clinically validated data processing pipeline, allowing localization of scalp EEG signal sources using co-registered MRI data and export of 3D electrode positions in DICOM format.
Persyst Development's software, Persyst 15, is FDA 510(k) cleared and holds CE/MDR, ONC, and ISO 13485 certifications, ensuring its adherence to medical device regulations. The company also complies with HIPAA, SOC 2, and ISO 27001 standards, demonstrating a strong commitment to data security and patient privacy.
Persyst offers comprehensive support and training, including direct phone support for urgent issues and scheduled remote sessions for non-urgent questions, configuration, licensing, and customized training. Their 'Persyst Primeu2122 Priority Support' program provides access to clinical application support, rapid resolution, and tailored training sessions to optimize workflows and system utilization.
Persyst is designed for seamless integration with major EEG acquisition systems from manufacturers like Natus, Nihon Kohden, Cadwell, Micromed, and Compumedics, and supports nearly 70 different data formats. It also integrates with hospital IT infrastructure, including PACS, Epic, and Cerner, to streamline workflows for imaging and patient data management.
Persyst 15 features a new, FDA-cleared Neonatal Seizure Detector that leverages deep learning and AI, operating effectively even on reduced electrode arrays. For neurocritical care, their ICU Continuous Monitoring product provides real-time trending, artifact reduction, and seizure/spike detection, designed for environments requiring comprehensive EEG capabilities.
Persyst operates on a subscription-based pricing model, with specific details available upon direct inquiry. They offer 'Persyst Primeu2122 Priority Support' which includes cost savings through indefinite renewals, volume discounts, and flexible licensing options to accommodate the needs of large institutions and ensure compatibility with evolving operating systems and EEG hardware.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.